{
"id":"mk19_bb_gm_s35",
"subspecialtyId":"gm",
"title":"Perioperative Medicine",
"jsonContent":{
"type":"section",
"id":"mk19_bb_gm_s35",
"title":{
"__html":"Perioperative Medicine"
},
"titleNode":{
"type":"section-title",
"hlId":"5e12df",
"children":[
"Perioperative Medicine"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_gm_s35_1",
"title":{
"__html":"Preoperative Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"ca23a4",
"children":[
"Preoperative Testing"
]
},
"children":[
{
"type":"p",
"hlId":"dd743c",
"children":[
{
"type":"alert",
"children":[
"Routine diagnostic testing is not indicated preoperatively."
]
},
" Do not obtain:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"5ad6c5",
"children":[
"routine preoperative laboratory studies in healthy patients undergoing elective or low-risk surgery"
]
},
" ",
{
"type":"list-item",
"hlId":"2dc434",
"children":[
"preoperative chest radiography in the absence of cardiopulmonary symptoms"
]
},
" "
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_gm_s35_inline_t1"
],
"forceOpen":true
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s35_2",
"title":{
"__html":"Cardiovascular Risk Assessment"
},
"titleNode":{
"type":"section-title",
"hlId":"f77292",
"children":[
"Cardiovascular Risk Assessment"
]
},
"children":[
{
"type":"p",
"hlId":"2104c0",
"children":[
"Risk factors for a major adverse cardiac event (",
{
"type":"abbreviation",
"title":"major adverse cardiac event",
"children":[
"MACE"
]
},
") include:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"dababe",
"children":[
"known ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"coronary artery disease",
"children":[
"CAD"
]
},
","
]
},
" cerebrovascular disease (",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"cerebrovascular accident",
"children":[
"CVA"
]
},
","
]
},
" ",
{
"type":"abbreviation",
"title":"transient ischemic attack",
"children":[
"TIA"
]
},
")"
]
},
" ",
{
"type":"list-item",
"hlId":"c63790",
"children":[
" ",
{
"type":"abbreviation",
"title":"chronic kidney disease",
"children":[
"CKD"
]
},
" "
]
},
" ",
{
"type":"list-item",
"hlId":"e8afc1",
"children":[
"diabetes mellitus"
]
},
" ",
{
"type":"list-item",
"hlId":"5d16f8",
"children":[
" ",
{
"type":"abbreviation",
"title":"heart failure",
"children":[
"HF"
]
},
" "
]
},
" "
]
},
{
"type":"p",
"hlId":"d960c0",
"children":[
"Patients with risk factors should undergo estimation of MACE risk using a validated risk calculator such as the Revised Cardiac Risk Index. Patients with an elevated risk of MACE ≥1% should have their functional capacity assessed with a standardized tool such as the Duke Activity Status Index. Patients with functional capacity ≥5 ",
{
"type":"abbreviation",
"title":"metabolic equivalents",
"children":[
"METs"
]
},
" are low risk and can proceed to surgery. Otherwise, preoperative cardiac stress testing should be considered but only if the results will change perioperative management."
]
},
{
"type":"p",
"hlId":"d1c016",
"children":[
"Obtain an ",
{
"type":"abbreviation",
"title":"electrocardiogram",
"children":[
"ECG"
]
},
" within 1 to 3 months of surgery (except low-risk surgery) in any patient with:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"eccb09",
"children":[
"CAD"
]
},
" ",
{
"type":"list-item",
"hlId":"312134",
"children":[
"significant arrhythmias"
]
},
" ",
{
"type":"list-item",
"hlId":"4e4cb5",
"children":[
"cerebrovascular disease (stroke or TIA)"
]
},
" ",
{
"type":"list-item",
"hlId":"bb4eea",
"children":[
" ",
{
"type":"abbreviation",
"title":"peripheral arterial disease",
"children":[
"PAD"
]
},
" "
]
},
" "
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"77bdff",
"children":[
"If a patient has no history, symptoms, or risk factors for CAD, no preoperative coronary evaluation is necessary."
]
},
" ",
{
"type":"list-item",
"hlId":"0da424",
"children":[
"Low-risk surgeries (cataract extraction, carpal tunnel release, breast biopsy, inguinal hernia repair) do not require cardiac testing even if a calculated risk score is elevated."
]
},
" ",
{
"type":"list-item",
"hlId":"fc9f5d",
"children":[
"No survival benefit is associated with revascularization in stable patients with CAD before noncardiac surgery unless they otherwise meet the general requirements for revascularization."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s35_3",
"title":{
"__html":"Cardiovascular Risk Management"
},
"titleNode":{
"type":"section-title",
"hlId":"32efc3",
"children":[
"Cardiovascular Risk Management"
]
},
"children":[
{
"type":"p",
"hlId":"579742",
"children":[
"Patients with a known recent MACE should not undergo elective surgery within:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"44fe71",
"children":[
"14 to 30 days of a bare-metal coronary stent implantation for stable CAD"
]
},
" ",
{
"type":"list-item",
"hlId":"18a447",
"children":[
"3 to 6 months of a drug-eluting coronary stent placement for stable CAD"
]
},
" ",
{
"type":"list-item",
"hlId":"7ac194",
"children":[
"12 months after ",
{
"type":"abbreviation",
"title":"acute coronary syndrome",
"children":[
"ACS"
]
}
]
},
" "
]
},
{
"type":"p",
"hlId":"30dc80",
"children":[
"Patients with hypertension who are undergoing surgery do not require urgent ",
{
"type":"abbreviation",
"title":"blood pressure",
"children":[
"BP"
]
},
" lowering preoperatively unless end-organ dysfunction is evident."
]
},
{
"type":"p",
"hlId":"d7d34e",
"children":[
"Most cardiac medications can be continued throughout the perioperative period. ",
{
"type":"abbreviation",
"title":"angiotensin-converting enzyme",
"children":[
"ACE"
]
},
" inhibitors and ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"angiotensin receptor blocker",
"children":[
"ARB"
]
},
"s"
]
},
" are typically withheld if prescribed for hypertension (unless BP is poorly controlled); diuretics are typically started as soon as possible postoperatively if prescribed for HF."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"5b0892",
"children":[
"Do not routinely initiate β-blockers before surgery to reduce cardiovascular risk."
]
},
" ",
{
"type":"list-item",
"hlId":"ae2b5c",
"children":[
"In the absence of ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"atherosclerotic cardiovascular disease",
"children":[
"ASCVD"
]
},
","
]
},
" do not routinely initiate statin therapy before surgery to reduce cardiovascular risk."
]
},
" ",
{
"type":"list-item",
"hlId":"60197d",
"children":[
"Do not use aspirin before surgery to reduce cardiovascular risk."
]
},
" ",
{
"type":"list-item",
"hlId":"1a059f",
"children":[
"Do not choose routine postoperative surveillance with ECG or cardiac biomarkers unless symptoms of an ACS are present."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s35_4",
"title":{
"__html":"Pulmonary Perioperative Management"
},
"titleNode":{
"type":"section-title",
"hlId":"c69e48",
"children":[
"Pulmonary Perioperative Management"
]
},
"children":[
{
"type":"p",
"hlId":"2d4dea",
"children":[
"Screen all surgical patients for ",
{
"type":"abbreviation",
"title":"obstructive sleep apnea",
"children":[
"OSA"
]
},
" with a validated tool such as the STOP-BANG survey. Obtain polysomnography for patients with presumed OSA and initiate ",
{
"type":"abbreviation",
"title":"continuous positive airway pressure",
"children":[
"CPAP"
]
},
" for patients with severe OSA undergoing high-risk elective surgical procedures."
]
},
{
"type":"p",
"hlId":"b95e0a",
"children":[
"Preoperative inspiratory muscle training can reduce perioperative pulmonary complication rates by up to 50%. Smoking cessation reduces pulmonary risk and should be encouraged as far in advance of surgery as possible."
]
},
{
"type":"p",
"hlId":"9e70e8",
"children":[
"Select early mobilization and lung expansion maneuvers (deep breathing exercises, incentive spirometry) to prevent pulmonary complications."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"eb21a4",
"children":[
"Do not order spirometry for risk assessment in the absence of dyspnea or hypoxia of uncertain cause."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s35_5",
"title":{
"__html":"Perioperative Management of Anticoagulant Therapy"
},
"titleNode":{
"type":"section-title",
"hlId":"849864",
"children":[
"Perioperative Management of Anticoagulant Therapy"
]
},
"children":[
{
"type":"p",
"hlId":"71bec9",
"children":[
"Anticoagulation must be stopped for most surgical procedures except those with minimal expected blood loss (cataract surgery, dermatologic procedures, endoscopic procedures without biopsy)."
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"38399e",
"children":[
"Stop warfarin 5 days before surgery."
]
},
" ",
{
"type":"list-item",
"hlId":"19c0ae",
"children":[
"Stop apixaban, rivaroxaban, and dabigatran 1 to 2 days before surgery if ",
{
"type":"abbreviation",
"title":"estimated glomerular filtration rate",
"children":[
"eGFR"
]
},
" >50 mL/min/1.73 m",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
". Stop earlier if eGFR is lower."
]
},
" "
]
},
{
"type":"p",
"hlId":"c566c3",
"children":[
"Bridging anticoagulation involves providing heparin during the perioperative period until an oral anticoagulant is resumed. Bridging should be considered only in patients taking warfarin with a high thrombotic risk:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"f82f06",
"children":[
"high-risk ",
{
"type":"abbreviation",
"title":"atrial fibrillation",
"children":[
"AF"
]
},
" (e.g., CHA",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"DS",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-VASc ≥7)"
]
},
" ",
{
"type":"list-item",
"hlId":"cfd450",
"children":[
"AF with mechanical valve"
]
},
" ",
{
"type":"list-item",
"hlId":"da5ef0",
"children":[
"AF with moderate to severe mitral stenosis"
]
},
" ",
{
"type":"list-item",
"hlId":"1d7d49",
"children":[
"older generation mechanical valves (ball-cage or tilting disc)"
]
},
" ",
{
"type":"list-item",
"hlId":"14c1fa",
"children":[
"recent thromboembolic event (e.g., CVA, TIA, ",
{
"type":"abbreviation",
"title":"venous thromboembolism",
"children":[
"VTE"
]
},
" within previous 3 mo)"
]
},
" ",
{
"type":"list-item",
"hlId":"f728b5",
"children":[
"aortic mechanical valve plus additional risk factor for thrombosis"
]
},
" ",
{
"type":"list-item",
"hlId":"18a1d9",
"children":[
"moderate to severe mitral stenosis"
]
},
" "
]
},
{
"type":"p",
"hlId":"2a1889",
"children":[
"Stopping and restarting perioperative anticoagulation:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"e33703",
"children":[
"Stop ",
{
"type":"abbreviation",
"title":"unfractionated heparin",
"children":[
"UFH"
]
},
" 4 to 6 hours before surgery."
]
},
" ",
{
"type":"list-item",
"hlId":"082000",
"children":[
"Stop ",
{
"type":"abbreviation",
"title":"low-molecular-weight heparin",
"children":[
"LMWH"
]
},
" 12 hours before surgery."
]
},
" ",
{
"type":"list-item",
"hlId":"66fa1d",
"children":[
"Restart heparin 24 hours after surgery."
]
},
" ",
{
"type":"list-item",
"hlId":"651e18",
"children":[
"Restart warfarin 12 to 24 hours after surgery."
]
},
" ",
{
"type":"list-item",
"hlId":"611499",
"children":[
"Restart dabigatran, rivaroxaban, and apixaban 24 hours after surgery."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s35_6",
"title":{
"__html":"Perioperative Management of Antiplatelet Therapy"
},
"titleNode":{
"type":"section-title",
"hlId":"b4e124",
"children":[
"Perioperative Management of Antiplatelet Therapy"
]
},
"children":[
{
"type":"p",
"hlId":"ec2566",
"children":[
"Dual antiplatelet therapy should be continued:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"796e60",
"children":[
"14 to 30 days after bare-metal stent placement for stable CAD"
]
},
" ",
{
"type":"list-item",
"hlId":"15e237",
"children":[
"3 to 6 months after drug-eluting stent placement for stable CAD"
]
},
" ",
{
"type":"list-item",
"hlId":"38dfb1",
"children":[
"≥1 year in patients following ACS"
]
},
" "
]
},
{
"type":"p",
"hlId":"2f8237",
"children":[
"Dual antiplatelet therapy should be restarted as soon as possible postoperatively."
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_gm_s35_inline_t1":{
"id":"mk19_bb_gm_s35_inline_t1",
"number":1,
"bookId":"gm",
"title":{
"__html":"Study Table: Select Indications for Preoperative Laboratory Testing"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"7a15de",
"children":[
"Study Table: Select Indications for Preoperative Laboratory Testing"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"675300",
"class":"col hd l",
"children":[
"Laboratory Test",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bf2781",
"class":"col hd l",
"children":[
"Preoperative Indications"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"172a9f",
"class":"cell txt l",
"children":[
"Hemoglobin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f1f553",
"class":"cell txt l",
"children":[
"History of anemia"
]
},
" ",
{
"type":"p",
"hlId":"e034c5",
"class":"cell txt l",
"children":[
"Signs/symptoms or examination findings suggesting anemia"
]
},
" ",
{
"type":"p",
"hlId":"a92e2d",
"class":"cell txt l",
"children":[
"Underlying disease that predisposes to anemia (e.g., kidney disease, myelodysplasia)"
]
},
" ",
{
"type":"p",
"hlId":"db055a",
"class":"cell txt l",
"children":[
"Expected substantial operative blood loss"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"65ed4c",
"class":"cell txt l",
"children":[
"Platelet count"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eec9c2",
"class":"cell txt l",
"children":[
"History of thrombocytopenia or cirrhosis; signs or symptoms of bleeding or liver disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4760b9",
"class":"cell txt l",
"children":[
"Coagulation studies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9ffeb",
"class":"cell txt l",
"children":[
"Warfarin or heparin use"
]
},
" ",
{
"type":"p",
"hlId":"b04d22",
"class":"cell txt l",
"children":[
"History of abnormal bleeding"
]
},
" ",
{
"type":"p",
"hlId":"210b2b",
"class":"cell txt l",
"children":[
"Medical conditions that predispose to coagulopathy (e.g., liver disease, nutritional disorders, hemophilia)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"06bcde",
"class":"cell txt l",
"children":[
"Electrolytes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e642b",
"class":"cell txt l",
"children":[
"Diseases that predispose to electrolyte derangements (e.g., kidney disease)"
]
},
" ",
{
"type":"p",
"hlId":"f65167",
"class":"cell txt l",
"children":[
"Use of medications that can cause electrolyte abnormalities (e.g., diuretics, ACE inhibitors, ARBs)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e33337",
"class":"cell txt l",
"children":[
"Creatinine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bad2e0",
"class":"cell txt l",
"children":[
"Kidney disease"
]
},
" ",
{
"type":"p",
"hlId":"6d2dc0",
"class":"cell txt l",
"children":[
"Expected large intraoperative fluid and BP shifts"
]
},
" ",
{
"type":"p",
"hlId":"f8181b",
"class":"cell txt l",
"children":[
"Used in preoperative cardiovascular risk calculators and for calculation of the ",
{
"type":"abbreviation",
"title":"Model for End-Stage Liver Disease",
"children":[
"MELD"
]
},
" score"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d310ea",
"class":"cell txt l",
"children":[
"Liver chemistry tests (including bilirubin)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"78a32c",
"class":"cell txt l",
"children":[
"Cirrhosis, history of abnormal liver chemistry tests, or signs or symptoms of liver disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"57a6a4",
"class":"cell txt l",
"children":[
"Fasting glucose and hemoglobin A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e01645",
"class":"cell txt l",
"children":[
"Known or suspected diabetes mellitus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"747c2a",
"class":"cell txt l",
"children":[
"Urinalysis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"619e8a",
"class":"cell txt l",
"children":[
"Suspected ",
{
"type":"abbreviation",
"title":"urinary tract infection",
"children":[
"UTI"
]
}
]
},
" ",
{
"type":"p",
"hlId":"39d9d3",
"class":"cell txt l",
"children":[
"Planned urologic procedures"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a661de",
"class":"cell txt l",
"children":[
"Pregnancy test"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d88163",
"class":"cell txt l",
"children":[
"Women of childbearing age"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"If patient is clinically stable and has no medication changes, tests other than pregnancy test need not be repeated if performed within 4 months of procedure."
]
]
}
}
}